Predictors of complete acute success in ventricular tachycardia ablation for patients with cardiac sarcoidosis

31 March 2025 (13:55 - 14:05)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Komandoor Srivathsan

Mayo Clinic, Mayo Clinic (United States of America)

5 More presentations in this session

Presentation thumbnail

Impact of COngenital substrate 3d Reconstruction to guide vt Catheter Ablation. the CORECA study

Doctor V. Waldmann (Paris, FR)

Abstract Slides Video

Presentation thumbnail

The two sides of the pericardial space - Omnipolar voltage and LAT differences on true epicardial vs. parietal pericardial surfaces during VT substrate mapping

Doctor J. Tonko (London, GB)

Abstract Slides Video

Presentation thumbnail

Long-term outcomes of ventricular tachycardia ablation in patients presenting with electrical storm

Doctor J. Certo Pereira (Carnaxide, PT)

Abstract Slides Video

Presentation thumbnail

First experience using a novel 3D enabled large-area focal pulsed field ablation catheter for ventricular ablation

Doctor T. Kueffer (Bern, CH)

Abstract Slides Video

Presentation thumbnail

Catheter ablation of premature ventricular contractions using an Alternative vascular access and Remote Magnetic navigation (ARM) approach

Doctor J. Griffiths (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Ventricular tachycardia ablation

The Event

Event poster

EHRA 2025

31 March 2025 13:55 CET

You may be interested in

Congress Presentation

A patient with cardiac sarcoidosis

Congress Presentation

Cardiac sarcoidosis and post-myocarditis

Congress Presentation

Weathering the VT storm: a case of refractory ventricular tachycardia (VT) storm in newly diagnosed isolated cardiac sarcoidosis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources